Her romidepsin regimen was switched to weekly brentuximab infusions, a CD30-directed monoclonal antibody that is used to treat anaplastic large-cell lymphoma by inducing apoptosis in CD30+ cells [13]. Here, TNFRSF8 is linked to anaplastic large cell lymphoma.